BridgeBio Pharma, Inc. (BBIO)

69.26 +1.12 (+1.64%) USD  |  NASDAQ  |  Feb 23, 09:52
More

BridgeBio Pharma Other Receivables (Quarterly)

Other Receivables (Quarterly) Chart

View Other Receivables (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Receivables (Quarterly) Range, Past 5 Years

View Other Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Receivables (Quarterly) Benchmarks

View Other Receivables (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade